French drugmaker Sanofi is nearing a decision to invest between 1.3 billion euros and 1.5 billion euros ($1.4-$1.6 billion) in a significant
French pharmaceutical company Sanofi has announced a collaboration with artificial intelligence (AI) firms OpenAI and Formation Bio to enhance its drug development
Novavax secures a licensing deal worth up to $1.2 billion with Sanofi for its COVID-19 vaccine, entailing a stake in Novavax valued